Patients with obesity who take GLP-1 receptor agonists in real-world settings lose significantly less weight than participants in randomized clinical trials, according to new research.
Health News is provided as a service to San Andreas Pharmacy site users by HealthDay. San Andreas Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.